With more than 170,000 people in New Jersey predicted to be living with Alzheimer’s disease this year, and that number only continuing to rise, the need to find a more effective diagnosis and treatment is becoming more and more dire.
The Press of Atlantic City recently spoke with Dr. David Levi about AMI’s role in the IDEAS study and why he is so proud to be involved. “I can say, personally, my grandmother had the disease and it’s a tough illness to watch. If we can make a difference in patients’ lives, be able to provide the typical level of service with a national trial, that’s what we’re about.”
To read the article in its entirety, click here: http://goo.gl/VtMLZA
